Google DeepMind launched AlphaGenome, an AI tool designed to identify genetic drivers of disease.
AlphaGenome predicts how DNA mutations disrupt gene regulation across different cells and tissues.
The system can analyse up to one million DNA letters at once.
Researchers trained the model using large public human and mouse genetics databases.
Most inherited diseases and many cancers stem from regulatory DNA mutations.
Scientists say the tool could accelerate discovery of disease-causing mutations.
AlphaGenome may also support development of targeted gene and drug therapies.
Andrew Rogers
Andrew Rogers is a freelance journalist based in the USA, with over 10 years of experience covering Politics, World Affairs, Business, Health, Technology, Finance, Lifestyle, and Culture. He earned his degree in Journalism from the University of Florida. Throughout his career, he has contributed to outlets such as The New York Times, CNN, and Reuters. Known for his clear reporting and in-depth analysis, Andrew delivers accurate and timely news that keeps readers informed on both national and international developments.
Add A Comment